the brain health medicines scholar award provides funding and drug development support to researchers whose work aims to treat, prevent or cure alzheimer's disease and related dementias.
cihr-ig is pleased to be partnering with approximately 34 international funding organizations in the context of this european rare diseases research alliance (erdera) joint transnational call (jtc) 2025. cihr-ig is committed to expanding and improving the diagnosis and treatment of rare diseases by creating the conditions needed to bring together creative, dynamic, interdisciplinary teams of researchers from across canada and the european community (ec) to collaborate for better health outcome for the rare disease patient community.
the topic of the call is pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.
projects should focus on a group of rare diseases or on a single rare disease if there is no valid rationale/evidence for the benefit of grouping diseases. if focusing on a single rare disease, applicants must clearly specify why working on a group of rare diseases is not appropriate. the classification of rare diseases follows the european definition, i.e. a disease affecting not more than five in 10,000 persons in the european community, ec associated states, and canada.
the specific objectives of this funding opportunity are to:
the forest sector investment and innovation program (fsiip) provides funding for strategic investments in the forest sector that:
support is available under two project categories – business projects and collaboration projects.
eligible applicants
eligible partners
the r&d partnership fund – electric vehicle (ev) – stream 2 program supports projects related to the development and demonstration of technologies in electric vehicles (ev) and battery manufacturing technologies in the following priority areas:
eligible applicants
eligible partners
the r&d partnership fund – c/av and smart mobility – stream 2 program supports projects related to the development, testing, validation, and demonstration of connected and autonomous vehicle (c/av) and smart mobility technologies in the following priority areas:
eligible applicants
eligible partners
the r&d partnership fund – advanced charging and v2g stream supports projects related to the development, validation, testing, piloting, demonstration, commercialization, and deployment of technologies, products and services focused on advanced charging and v2g technologies needed to accelerate the shift to electrification. this includes technologies in the following priority areas:
webinar: thcs offers will offer an information webinar to introduce the jtc 2025 on 17 december 2024 (14:00-16:00 cet / 8:00-10:00am et). click here to register for the webinar.
the european partnership on transforming health and care systems (thcs) brings the opportunity to coordinate and optimize research and innovation efforts in europe and its partner countries supporting the much-needed transformation of health and care systems.
under this umbrella, the third joint transnational call for proposals “better care closer to home: enhancing primary and community care” aims to improve primary and community health and care systems, providing policymakers with knowledge and tools to manage transitions within the primary and community care sector. projects funded under this call will deliver promising financial, organizational, and practice-based service innovations that promote the transformation of health and care systems and contribute to faster exchange of best practices across different countries and regions.
to align regional and national research strategies and funding activities, promote excellence, reinforce the competitiveness of european players while fostering eu cooperation and enhance european collaboration with non-eu countries, 34 funding organisations have agreed to launch the joint transnational call 2025 (jtc2025) for collaborative, innovative research projects co-funded by the european union. the funding organisations participating in this call particularly wish to promote innovative, interdisciplinary collaboration and encourage transnational collaboration.
proposals are submitted by a transnational "consortium." the consortium must include at least three (3) eligible partners from three different countries whose funding organisations participate in the call. at least two (2) members of the consortium should be legal entities from two different eu member states or horizon europe associated countries. each of these partners must be eligible and request funding from the respective funding organisation. all three legal entities must be independent of each other. funders from the following countries are participating in this call: austria, belgium, canada, czech republic, denmark, estonia, finland, france, iceland, ireland, israel, italy, lithuania, malta, the netherlands, norway, poland, portugal, spain, sweden, switzerland.
in canada, cihr is funding canadian participation in this call. the maximum funding amount is $300,000 cad per canadian partner. cihr's additional eligibility for this call is follows: projects must be focused on the health and care of older persons and/or their caregivers and use a patient-oriented research approach. patient-oriented research (por) involves engaging patients, caregivers, families, communities as well as knowledge users and decision makers as partners in co-creating research. this partnered approach is a key element of research excellence and increases the quality, relevance, and impact of research evidence, increasing its uptake into health policy and practice. projects therefore must include a patient engagement plan with details on how people with lived and living experience (pwlle) and/or communities, including indigenous, will be part of the research team, designing and executing the research and subsequent knowledge mobilization. for more information, please also refer to spor’s patient engagement framework.. please note, a parallel submission to cihr is not required.
stage 1
stage 2
the objective of idea to innovation (i2i) grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector, and to promote its transfer to a new or established canadian company. i2i grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. this is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.
